CoChat

RT-QuIC detection of tauopathies using full-length tau substrates

Open access
Tennant, Joanne M., Henderson, Davin M., Wisniewski, Thomas M., Hoover, Edward A. · 2020 · Prion

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Early detection and diagnosis of neurodegenerative diseases has been hampered by the lack of sensitive testing. Real-time quaking induced conversion (RT-QuIC) has been used for the early and sensitive detection of prion-induced neurologic disease, and has more recently been adapted to detect misfolded alpha-synuclein and tau as biomarkers for neurodegenerative disease. Here we use full-length recombinant tau substrates to detect tau seeding activity in Alzheimer's disease and other human tauopathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19336896.2020.1832946

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Tau seeding range. (a) Representative ThT fluorescence curves for AD1 brain over 10-fold dilutions of the pellet seeded onto either 2N3R, 2N4R, or both 2N3R/2N4R recombinant tau substrates. Each dilution has four replicates represented. (b) Plotted hours to threshold for 2 separate AD, one Pick’s disease brain, and one no disease control brain over 10-fold dilutions of 2N3R, 2N4R, or 2N3R/2N4R mixed substrate
Figure 1. Tau seeding range. (a) Representative ThT fluorescence curves for AD1 brain over 10-fold dilutions of the pellet seeded onto either 2N3R, 2N4R, or both 2N3R/2N4R recombinant tau substrates. Each dilution has four replicates represented. (b) Plotted hours to threshold for 2 separate AD, one Pick’s disease brain, and one no disease control brain over 10-fold dilutions of 2N3R, 2N4R, or 2N3R/2N4R mixed substrateCC BY · PubMed Central
Figure 2. Tauopathy detection using 2N3R substrate: (a) ThT fluorescence curves for AD, Pick’s, and PSP diseased brains as well as 2 no disease brain controls. (b) Time to threshold for 11 AD, 4 Pick’s, 3 PSP, and 2 FTLD disease brains, and 2 no disease controls. All diseased brain samples were statistically different from the negative controls. Sensitivity is good for 3 R and even 4 R disease, but control brain background is high
Figure 2. Tauopathy detection using 2N3R substrate: (a) ThT fluorescence curves for AD, Pick’s, and PSP diseased brains as well as 2 no disease brain controls. (b) Time to threshold for 11 AD, 4 Pick’s, 3 PSP, and 2 FTLD disease brains, and 2 no disease controls. All diseased brain samples were statistically different from the negative controls. Sensitivity is good for 3 R and even 4 R disease, but control brain background is highCC BY · PubMed Central
Figure 3. Tauopathy detection with 2N4R substrate. (a) ThT fluorescence curves for AD, Pick’s, PSP, and no disease brain controls in 2N4R substrate. (b) Time to threshold for 11 AD, 4 Pick’s, 3 PSP, 2 FTLD brains and age-appropriate no-disease controls in 2N4R only substrate. Eight replicates for each sample are shown. Detection signals are lengthened and reduced for mixed ((3 R/4 R)(AD) and 3 R (PiD) diseases
Figure 3. Tauopathy detection with 2N4R substrate. (a) ThT fluorescence curves for AD, Pick’s, PSP, and no disease brain controls in 2N4R substrate. (b) Time to threshold for 11 AD, 4 Pick’s, 3 PSP, 2 FTLD brains and age-appropriate no-disease controls in 2N4R only substrate. Eight replicates for each sample are shown. Detection signals are lengthened and reduced for mixed ((3 R/4 R)(AD) and 3 R (PiD) diseasesCC BY · PubMed Central
Figure 4. Tauopathy detection with 2N3R/2N4R substrate mixture. (a) ThT fluorescence curves for AD, Pick’s, PSP and no-disease brain controls using a 50:50 molar mix of 2N3R/2N4R substrate. (b) Time to threshold for 11 AD, 4 Pick’s, 3 PSP, and 2 FTLD brains and 2 no-disease controls in 2N3R/2N4R substrate, 1:100 brain dilution. Eight replicates for each sample are shown. Combined 3 R-4 R r-tau substrate produced the best compromise of sensitivity and selectivity vs. age-appropriate no-disease control brains
Figure 4. Tauopathy detection with 2N3R/2N4R substrate mixture. (a) ThT fluorescence curves for AD, Pick’s, PSP and no-disease brain controls using a 50:50 molar mix of 2N3R/2N4R substrate. (b) Time to threshold for 11 AD, 4 Pick’s, 3 PSP, and 2 FTLD brains and 2 no-disease controls in 2N3R/2N4R substrate, 1:100 brain dilution. Eight replicates for each sample are shown. Combined 3 R-4 R r-tau substrate produced the best compromise of sensitivity and selectivity vs. age-appropriate no-disease control brainsCC BY · PubMed Central
Figure 5. Preclinical detection of tauopathy in mice. Tau seeding activity was detected in brains of P301S mice collected at 3, 6, 9, and 12-months of age using the equimolar 2N4R/2N3R r-tau substrate. Data shown are based on 3–4 mouse pooled mouse brains at each timepoint. Y axis = time to threshold crossing
Figure 5. Preclinical detection of tauopathy in mice. Tau seeding activity was detected in brains of P301S mice collected at 3, 6, 9, and 12-months of age using the equimolar 2N4R/2N3R r-tau substrate. Data shown are based on 3–4 mouse pooled mouse brains at each timepoint. Y axis = time to threshold crossingCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 34

Metadata

Authors
Tennant, J. M., Henderson, D. M., Wisniewski, T. M., & Hoover, E. A.
Affiliations
  • Colorado State University (US)
  • Center for Cognitive Neurology and Departments of Neurology, Pathology and Psychiatry, NYU School of Medicine , New York, NY, USA
Corresponding author
Hoover, Edward A.
Venue
Prion
Published
2020-01-01
Volume
14
Issue
1
Pages
249-256
ISSN
  • 1933-6896 (ISSN-L)
  • 1933-690X
OpenAlex
W3102896409
Cited by
31
References
34
Citations by year
2026: 4 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 4 · 2021: 2
FWCI
2.25
Type
journal article
Language
en
Open access
Locations
  • Prion (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Congressionally Directed Medical Research
  • Peer Reviewed Alzheimer’s Disease Research Program, Convergence Science Research Award Program
  • The Brain and Body Donation Program
  • National Institute on Aging (P30 AG19610 Arizona Alzheimer’s Disease Core Center)
  • the Arizona Biomedical Research Commission
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
RT-QuIC, tauopathy, Alzheimer's disease, neurodegenerative disease biomarkers, tau misfolding, prion-like seeding
MeSH terms
Animals, Biological Assay, Brain, Humans, Substrate Specificity, tau Proteins, Tauopathies, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.